An Immunity Persistence Study of Live Attenuated Varicella Vaccine
Clinical trial NCT05095701 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05095701
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-18
- Primary completion
- 2021-12-19
- Enrollment
- 703
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.